Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Type of study
Publication year range
1.
J Diet Suppl ; 15(3): 269-284, 2018 May 04.
Article in English | MEDLINE | ID: mdl-28800275

ABSTRACT

Parquetina nigrescens is commonly used to treat diseases in humans and animals in developing countries, including Nigeria. This study evaluates the effects of its polyphenol-rich fraction (prf) on dichlorvos-induced cardio- and renal toxicity. There were several factors assessed during this study, including cardiac and renal markers, serum myeloperoxidase and xanthine oxidase, and electrocardiograph (ECG) changes. The changes in electrocardiograph (ECG) were recorded. Immunohistochemistry of cardiac and renal p38 and nitrotyrosine was determined. Dichlorvos exposure caused a significant decrease in L-glutathione (reduced glutathione) and other antioxidant enzymes with increases in malondialdehyde, myeloperoxidase, advanced oxidation protein products, and protein carbonyl levels. It also brought about alterations in microanatomy of the heart and kidneys accompanied by increases in serum creatinine and urea levels. Exposure to dichlorvos induced prolonged QRS interval and shortened QT durations in rats. Immunohistochemistry revealed lower expressions of cardiac nitrotyrosine and renal p38 (mitogen-activated protein kinase; MAPK) in rats treated with prf of P. nigrescens. Combining all, prf of P. nigrescens demonstrated antioxidant as well as protective properties in the heart and kidneys of rats exposed to dichlorvos. It ameliorated dichlorvos-induced cardio- and nephrotoxicity giving credence to its use in ethnomedicine.


Subject(s)
Cryptolepis/chemistry , Dietary Supplements , Organophosphate Poisoning/prevention & control , Plant Components, Aerial/chemistry , Plant Extracts/therapeutic use , Polyphenols/therapeutic use , Protective Agents/therapeutic use , Administration, Oral , Animals , Biomarkers/blood , Biomarkers/metabolism , Cryptolepis/growth & development , Dichlorvos/administration & dosage , Dichlorvos/antagonists & inhibitors , Dichlorvos/toxicity , Dietary Supplements/analysis , Heart Ventricles/drug effects , Heart Ventricles/metabolism , Heart Ventricles/pathology , Heart Ventricles/physiopathology , Insecticides/administration & dosage , Insecticides/antagonists & inhibitors , Insecticides/toxicity , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Kidney/physiopathology , Male , Nigeria , Organophosphate Poisoning/metabolism , Organophosphate Poisoning/pathology , Organophosphate Poisoning/physiopathology , Plant Components, Aerial/growth & development , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Polyphenols/administration & dosage , Polyphenols/analysis , Polyphenols/isolation & purification , Protective Agents/administration & dosage , Protective Agents/chemistry , Protective Agents/isolation & purification , Random Allocation , Rats, Wistar , Renal Insufficiency/etiology , Renal Insufficiency/prevention & control , Tyrosine/agonists , Tyrosine/analogs & derivatives , Tyrosine/antagonists & inhibitors , Tyrosine/metabolism , Ventricular Dysfunction/etiology , Ventricular Dysfunction/prevention & control , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/chemistry , p38 Mitogen-Activated Protein Kinases/metabolism
2.
Bull Exp Biol Med ; 161(6): 779-781, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27783305

ABSTRACT

Experiments on white non-inbred rats demonstrated that treatment with organophosphorus compound dimethyl dichlorovinyl phosphate (DDVP) decreased T cell-independent antibody production by B cells and blood levels of IL-10 and IL-12; a similar effect was produced by GTS-21, a selective agonist of α7-nicotinic acetylcholine receptor. N-nicotinic receptor antagonist chlorisondamine in combination with DDVP partially prevented suppression of antibody production in comparison with the effect observed during intoxication with DDVP.


Subject(s)
B-Lymphocytes/drug effects , Chlorisondamine/pharmacology , Cholinesterase Inhibitors/toxicity , Dichlorvos/toxicity , Nicotinic Antagonists/pharmacology , alpha7 Nicotinic Acetylcholine Receptor/immunology , Animals , Animals, Outbred Strains , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Benzylidene Compounds/pharmacology , Cholinesterase Inhibitors/immunology , Dichlorvos/antagonists & inhibitors , Dichlorvos/immunology , Female , Immunoglobulin M/biosynthesis , Injections, Intramuscular , Interleukin-10/biosynthesis , Interleukin-10/metabolism , Interleukin-12/biosynthesis , Interleukin-12/metabolism , Male , Nicotinic Agonists/pharmacology , Pyridines/pharmacology , Rats , Spleen/cytology , Spleen/drug effects , Spleen/immunology , alpha7 Nicotinic Acetylcholine Receptor/metabolism
3.
ACS Nano ; 9(6): 6450-8, 2015 Jun 23.
Article in English | MEDLINE | ID: mdl-26053868

ABSTRACT

Organophosphate poisoning is highly lethal as organophosphates, which are commonly found in insecticides and nerve agents, cause irreversible phosphorylation and inactivation of acetylcholinesterase (AChE), leading to neuromuscular disorders via accumulation of acetylcholine in the body. Direct interception of organophosphates in the systemic circulation thus provides a desirable strategy in treatment of the condition. Inspired by the presence of AChE on red blood cell (RBC) membranes, we explored a biomimetic nanoparticle consisting of a polymeric core surrounded by RBC membranes to serve as an anti-organophosphate agent. Through in vitro studies, we demonstrated that the biomimetic nanoparticles retain the enzymatic activity of membrane-bound AChE and are able to bind to a model organophosphate, dichlorvos, precluding its inhibitory effect on other enzymatic substrates. In a mouse model of organophosphate poisoning, the nanoparticles were shown to improve the AChE activity in the blood and markedly improved the survival of dichlorvos-challenged mice.


Subject(s)
Biomimetic Materials/pharmacology , Dichlorvos/antagonists & inhibitors , Nanoparticles/chemistry , Organophosphate Poisoning/drug therapy , Acetylcholinesterase/metabolism , Animals , Biomimetic Materials/chemistry , Dichlorvos/administration & dosage , Dichlorvos/toxicity , Disease Models, Animal , Erythrocytes/drug effects , Erythrocytes/metabolism , Male , Mice , Mice, Inbred Strains
4.
Mol Neurobiol ; 49(1): 163-75, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23884618

ABSTRACT

The neurotoxic consequences of acute high-level as well as chronic low-level organophosphates exposure are associated with a range of abnormalities in nerve functions. Previously, we have shown that after 24 h of dichlorvos exposure, microglia become activated and secrete pro-inflammatory molecules like nitric oxide, tumour necrosis factor-α and interleukin-1ß. Here, we extended our findings and focused on the neuronal damage caused by dichlorvos via microglial activation. For this, neurons and microglia were isolated separately from 1-day-old Wistar rat pups. Microglia were treated with dichlorvos for 24 h and supernatant was collected (dichlorvos-induced conditioned medium, DCM). However, when 4-hydroxy TEMPO (4-HT) pretreatment was given, we observed significant attenuation of dichlorvos-induced microglial activation; we also collected the supernatant of this culture (4-HT + DCM, TDCM). Next, we checked the effects of DCM on neurons and found heavy loss in viability as evident from NF-H immunostaining and MTT results, whereas dichlorvos alone-treated neurons showed comparatively less damage. However, we observed significant increase in neuronal viability when cells were treated with TDCM. Semi-quantitative PCR and western blot results revealed significant increase in p53, Bax and cytochrome c levels along with caspase 3 activation after 24 h of DCM treatment. However, TDCM-treated neurons showed significant decrease in the expression of these pro-apoptotic molecules. Taken together, these findings suggest that 4-HT can significantly attenuate dichlorvos-induced microglial activation and prevent apoptotic neuronal cell death.


Subject(s)
Apoptosis/drug effects , Cyclic N-Oxides/pharmacology , Dichlorvos/toxicity , Hydroxylamine/pharmacology , Microglia/drug effects , Neurons/drug effects , Animals , Animals, Newborn , Apoptosis/physiology , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Dichlorvos/antagonists & inhibitors , Male , Microglia/metabolism , Neurons/metabolism , Rats , Rats, Wistar
5.
Toxicol Appl Pharmacol ; 256(1): 73-82, 2011 Oct 01.
Article in English | MEDLINE | ID: mdl-21843543

ABSTRACT

Numerous epidemiological studies have shown an association between pesticide exposure and increased risk of developing Parkinson's diseases. Oxidative stress generated as a result of mitochondrial dysfunction has been implicated as an important factor in the etiology of Parkinson's disease. Previously, we reported that chronic dichlorvos exposure causes mitochondrial impairments and nigrostriatal neuronal death in rats. The present study was designed to test whether Coenzyme Q(10) (CoQ(10)) administration has any neuroprotective effect against dichlorvos mediated nigrostriatal neuronal death, α-synuclein aggregation, and motor dysfunction. Male albino rats were administered dichlorvos by subcutaneous injection at a dose of 2.5 mg/kg body weight over a period of 12 weeks. Results obtained there after showed that dichlorvos exposure leads to enhanced mitochondrial ROS production, α-synuclein aggregation, decreased dopamine and its metabolite levels resulting in nigrostriatal neurodegeneration. Pretreatment by Coenzyme Q(10) (4.5 mg/kg ip for 12 weeks) to dichlorvos treated animals significantly attenuated the extent of nigrostriatal neuronal damage, in terms of decreased ROS production, increased dopamine and its metabolite levels, and restoration of motor dysfunction when compared to dichlorvos treated animals. Thus, the present study shows that Coenzyme Q(10) administration may attenuate dichlorvos induced nigrostriatal neurodegeneration, α-synuclein aggregation and motor dysfunction by virtue of its antioxidant action.


Subject(s)
Dichlorvos/toxicity , Neurons/enzymology , Neuroprotective Agents/administration & dosage , Oxidative Stress/drug effects , Ubiquinone/analogs & derivatives , Animals , Cell Death/drug effects , Cell Death/physiology , Dichlorvos/antagonists & inhibitors , Male , Neurons/drug effects , Neurons/pathology , Neuroprotective Agents/therapeutic use , Oxidative Stress/physiology , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Ubiquinone/administration & dosage , Ubiquinone/therapeutic use
6.
J Occup Health ; 47(2): 96-101, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15824473

ABSTRACT

The changes of N-methyl-D-aspartate (NMDA) receptor and protective efficacy of memantine (MEM) in rats poisoned with dichlorvos were studied. Dichlorvos evoked down-regulation of the affinity and density of [(3)H]MK-801 binding to NMDA receptor in the brain of rats receiving dichlorvos (15 and 25 mg/kg bw, i.p.). The binding capacity of NMDA receptor and acetylcholinesterase activity were determined at 4 h, 8 h, 16 h, 24 h and 48 h after treatment. When rats were given a different doses of MEM (5, 15 and 45 mg/kg bw) after poisoning (dichlorvos 25 mg/kg bw), the latency of onset of signs was postponed and the magnitude of muscular fasciculation was alleviated as the dose of MEM increased. The lower doses of MEM (5 and 15 mg/kg bw) could antagonize the dichlorvos-evoked down-regulation of NMDA receptor, while the highest dose (45 mg/kg bw) decreased the Bmax and Kd values of NMDA receptors. These results show the dichlorvos-evoked down-regulation of NMDA receptor might be self-regulation by the body to protect the central nervous system. MEM could antagonize the down-regulation of NMDA receptors, and alleviated signs of poisoning, especially reducing the magnitude of muscular fasciculation. We suggest that the role of NMDA receptor in organophosphates (OP) poisoning should receive more attention, and, that MEM treatment in acute OP poisoning, as a supplement to atropine and oxime, should be considered.


Subject(s)
Brain/drug effects , Dichlorvos/toxicity , Excitatory Amino Acid Antagonists/therapeutic use , Insecticides/toxicity , Memantine/therapeutic use , Receptors, N-Methyl-D-Aspartate/drug effects , Acetylcholinesterase/metabolism , Animals , Brain/enzymology , Brain/metabolism , Dichlorvos/antagonists & inhibitors , Insecticides/antagonists & inhibitors , Male , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/metabolism
7.
Basic Clin Pharmacol Toxicol ; 96(2): 111-7, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15679473

ABSTRACT

The aim of the study was to examine antidotal potency of trimedoxime in mice poisoned with three direct dimethoxy-substituted organophosphorus inhibitors. In order to assess the protective efficacy of trimedoxime against dichlorvos, heptenophos or monocrotophos, median effective doses and efficacy half-times were calculated. Trimedoxime (24 mg/kg intravenously) was injected 5 min. before 1.3 LD50 intravenously of poisons. Activities of brain, diaphragmal and erythrocyte acetylcholinesterase, as well as of plasma carboxylesterases were determined at different time intervals (10, 40 and 60 min.) after administration of the antidotes. Protective effect of trimedoxime decreased according to the following order: monocrotophos > heptenophos > dichlorvos. Administration of the oxime produced a significant reactivation of central and peripheral acetylcholinesterase inhibited with dichlorvos and heptenophos, with the exception of erythrocyte acetylcholinesterase inhibited by heptenophos. Surprisingly, trimedoxime did not induce reactivation of monocrotophos-inhibited acetylcholinesterase in any of the tissues tested. These organophosphorus compounds produced a significant inhibition of plasma carboxylesterase activity, while administration of trimedoxime led to regeneration of the enzyme activity. The same dose of trimedoxime assured survival of experimental animals poisoned by all three organophosphorus compounds, although the biochemical findings were quite different.


Subject(s)
Dichlorvos/poisoning , Monocrotophos/poisoning , Organophosphate Poisoning , Trimedoxime/therapeutic use , Acetylcholine/chemistry , Acetylcholine/metabolism , Animals , Brain Chemistry/drug effects , Carboxylesterase/antagonists & inhibitors , Carboxylesterase/blood , Carboxylesterase/drug effects , Diaphragm/drug effects , Diaphragm/physiology , Dichlorvos/administration & dosage , Dichlorvos/antagonists & inhibitors , Drug Evaluation, Preclinical/methods , Erythrocytes/chemistry , Erythrocytes/drug effects , Erythrocytes/physiology , Injections, Intravenous , Lethal Dose 50 , Male , Mice , Monocrotophos/administration & dosage , Monocrotophos/antagonists & inhibitors , Organophosphorus Compounds/administration & dosage , Organophosphorus Compounds/antagonists & inhibitors , Oximes/administration & dosage , Oximes/pharmacology , Oximes/therapeutic use , Time Factors , Trimedoxime/administration & dosage , Trimedoxime/pharmacokinetics
8.
Vet Res Commun ; 13(2): 127-33, 1989.
Article in English | MEDLINE | ID: mdl-2505441

ABSTRACT

Five French Alpine goats received 2 mg kg-1 of dichlorvos (DDVP) by intravenous injection and 0.15 mg kg-1 of atropine sulphate 5-10 min later. Ventilatory mechanics, gas exchanges, pulmonary haemodynamics and pulmonary vascular resistance (PVR) were measured before treatment, 5 min after DDVP injection and 5 min after atropine injection. Within 2 min of DDVP administration, all the goats showed acute respiratory distress, excitation and slight muscle fasciculations. A post-inspiratory pause was recorded in 3 goats. Hypersecretion of saliva or nasal discharge was not observed. Dynamic compliance and heart rate decreased significantly and total pulmonary resistance, pulmonary artery and wedge pressures increased significantly. On the other hand, minute ventilation, arterial oxygen and carbon dioxide tensions were not significantly altered by DDVP. Atropine treatment reversed all the clinical and functional parameters, with the exception of the central nervous and muscular signs, which disappeared within 12 h. It was concluded that experimental DDVP toxicosis induced changes in the mechanics of breathing and pulmonary haemodynamics associated with diffuse bronchoconstriction and cardiac insufficiency respectively.


Subject(s)
Atropine/pharmacology , Dichlorvos/poisoning , Goats , Lung/drug effects , Respiration/drug effects , Animals , Blood Flow Velocity/drug effects , Blood Gas Analysis/veterinary , Carbon Dioxide/blood , Dichlorvos/administration & dosage , Dichlorvos/antagonists & inhibitors , Heart Rate/drug effects , Hemodynamics/drug effects , Injections, Intravenous/veterinary , Lung/physiology , Male , Oxygen/blood , Pulmonary Gas Exchange/drug effects , Pulmonary Wedge Pressure/drug effects , Rats , Tidal Volume/veterinary , Vascular Resistance/drug effects
9.
Neurotoxicol Teratol ; 9(3): 197-201, 1987.
Article in English | MEDLINE | ID: mdl-3627083

ABSTRACT

Dichlorvos (dimethyl 2,2-dichlorovinyl phosphate) was administered orally to German Shorthair Pointer dogs at approximately 60 mg/kg (twice the usual clinical dose). Plasma and erythrocyte cholinesterase (ChE) was monitored prior to, 90 min, and 180 min post-ingestion. 2-PAM (20 mg/kg IV) and atropine sulfate (0.022 mg/kg IM) were administered 90 min after the dichlorvos to paired treated and control dogs. The telemetered electrocardiographic (ECG) signal was analyzed by a Vagal Tone Monitor (VTM) to yield mean heart period (msec) and an estimate of the amplitude of respiratory sinus arrhythmia (V in natural log values of msec2) for five min intervals. Dichlorvos did not cause cholinomimetic symptoms even though blood cholinesterase was significantly inhibited (plasma -51.3% and erythrocyte -43.7%). The atropine sulfate treatment resulted in the expected vagolytic effects in both the control and the dichlorvos treated dogs, but the atropine effects were attenuated in the latter dogs. Three weeks later, ChE activity was not significantly depressed in the dichlorvos treated dogs, and their V responses to atropine were more similar to the responses in control dogs.


Subject(s)
Dichlorvos/toxicity , Nervous System Diseases/chemically induced , Vagus Nerve/physiopathology , Animals , Atropine/therapeutic use , Cholinesterases/blood , Dichlorvos/antagonists & inhibitors , Dogs , Erythrocytes/enzymology , Monitoring, Physiologic , Nervous System Diseases/physiopathology , Pralidoxime Compounds/therapeutic use
10.
Jpn J Pharmacol ; 41(3): 267-71, 1986 Jul.
Article in English | MEDLINE | ID: mdl-3761745

ABSTRACT

Diethyxime, a non-quaternary cholinesterase reactivator was evaluated for its antidotal efficacy against organophosphorus intoxication in rats using the protection index, cholinesterase reactivation and neuromuscular function as the experimental protocol. Diethyxime along with atropine produced a marked antidotal effect against dimethyl dichlorovinyl phosphate (DDVP) poisoning on all the parameters studied. The action of diethyxime was mainly peripheral. The protective efficacy against diisopropyl fluorophosphate (DFP) poisoning was not observed with this reactivator.


Subject(s)
Cholinesterase Reactivators/therapeutic use , Dichlorvos/antagonists & inhibitors , Isoflurophate/antagonists & inhibitors , Oximes/therapeutic use , Animals , Antidotes , Atropine/pharmacology , Bradycardia/chemically induced , Cholinesterases/blood , Neuromuscular Diseases/chemically induced , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...